(Q52168809)

26 April 2018

title

Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice. (English)

1 reference

26 April 2018

author name string

H E Shannon

1

1 reference

26 April 2018

K Rasmussen

2

1 reference

26 April 2018

F P Bymaster

3

1 reference

26 April 2018

J C Hart

4

1 reference

26 April 2018

S C Peters

5

1 reference

26 April 2018

M D Swedberg

6

1 reference

26 April 2018

L Jeppesen

7

1 reference

26 April 2018

M J Sheardown

8

1 reference

26 April 2018

P Sauerberg

9

1 reference

26 April 2018

A Fink-Jensen

10

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 May 2000

1 reference

26 April 2018

published in

Schizophrenia Research

1 reference

26 April 2018

volume

42

1 reference

26 April 2018

issue

3

1 reference

26 April 2018

page(s)

249-259

1 reference

26 April 2018

Pharmacological Specificity of Conditioned Avoidance Response Inhibition in Rats: Inhibition by Neuroleptics and Correlation to Dopamine Receptor Blockade

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Inhibition of SKF 38393- and pergolide-induced circling in rats with unilateral 6-OHDA lesion is correlated to dopamine D-1 and D-2 receptor affinities in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane .

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

The mesolimbic system, denervation and the climbing response in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Climbing behaviour induced by apomorphine in mice: A potential model for the detection of neuroleptic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Physostigmine ameliorates the delusions of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Muscarinic agonist inhibition of rat striatal adenylate cyclase is enhanced by dopamine stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Modulation of apomorphine-induced rotations in unilaterally 6-hydroxydopamine lesioned rats by cholinergic agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Seroquel: electrophysiological profile of a potential atypical antipsychotic

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Cholinergic modulation of [3H]dopamine release from dendrosomes of rat substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Utilization of microdialysis for assessing the release of mesotelencephalic dopamine following clozapine and other antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Antagonism of striatal muscarinic receptors inhibiting dopamine D1 receptor-stimulated adenylyl cyclase activity by cholinoceptor antagonist used to treat Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Muscarinic receptors modulate dopamine-activated adenylate cyclase of rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

A metaanalysis of controlled trials of neuroleptic treatment in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Schizophrenia and Alzheimer's disease: clinical and pathophysiologic analogies

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

Schizophrenia research moves to the prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900138-3

7 January 2021

10.1016/S0920-9964(99)00138-3

Identifiers

DOI

1 reference

26 April 2018

1 reference

26 April 2018